Blood Chemistry Monitoring

Clinicians value blood chemistry not only for detecting specific risk signals but for the holistic picture of patient health it provides. Hospitals relying on external laboratories face formatting incompatibilities, delays chasing results, and workflow disruption, while those with internal or partner-site labs can receive and integrate results quickly via EPR. The frequency of blood chemistry testing varies depending on which specific drugs are prescribed. All interviewed clinicians confirmed that blood chemistry review is a mandatory core component of chemotherapy delivery required by clinical protocol before every treatment cycle. Standard protocols often require blood chemistry review before each cycle regardless of how low a patient's perceived risk is. Delays in receiving blood chemistry results are commonly caused by external laboratory workflows and incompatible data formats that are difficult to integrate into electronic patient record systems.